Estée Lauder
Up to $5,000
Claims opening soon
Consumers and third-party payers who indirectly purchased certain generic drugs may be eligible for a portion of this $200 million class action settlement.
Allegations of antitrust violations related to the pricing of certain generic drugs.
This class action settlement resolves claims that Sun Pharmaceutical and Taro Pharmaceuticals engaged in antitrust practices leading to overpayment for certain generic drugs. Eligible individuals and entities in the U.S. (excluding Indiana and Ohio) who purchased, paid for, or were reimbursed for these drugs between May 1, 2009, and Dec. 31, 2019, may be eligible to file a claim.
Closed settlement
Claim status: Closed on November 9, 2026
Estée Lauder
Up to $5,000
Claims opening soon
Audible
Compensation pending
Claims opening soon
Government of Canada
Up to $200,000
615 days left

Meta (Facebook)
Up to $90
Claims opening soon
Ticketmaster
Compensation pending
Claims opening soon
Apple
Up to $100
Claims opening soon